CELL & GENE THERAPY INSIGHTS

Apr 2018. Vol 4 Issue 4

Apr 2018

FEATURING

Issue Spotlight: Latest Advances in CAR-T Cell Manufacture & Clinical Developments
Other articles
Webinar

Spotlight

Latest Advances in CAR-T Cell Manufacture & Clinical Developments
Apr 2018
Guest Editor:
Bruce Levine
Bruce Levine, Professor at University of Pennsylvania
Bruce Levine
Bruce Levine
Professor at University of Pennsylvania

Expert Insight

Advances in Targeting CAR-T Therapy for Immune-Mediated Diseases

Advances in Targeting CAR-T Therapy for Immune-Mediated Diseases
Jinmin Lee,
Aimee S Payne
14 May 2018
Expert Insight
Read more
Overcoming Challenges for Engineered Autologous T Cell Therapies

Overcoming Challenges for Engineered Autologous T Cell Therapies
Marc Better,
Vijay Chiruvolu,
Marianna Sabatino
14 May 2018
Expert Insight
Read more
Ethical Considerations in the Translation of CAR-T Cell Therapies

Ethical Considerations in the Translation of CAR-T Cell Therapies
Kathleen Imbach,
Arjun Patel,
Aaron D Levine
14 May 2018
Expert Insight
Read more
Strategies to Control CAR-T Cell Therapy: Perspective on Next-Generation CARs

Strategies to Control CAR-T Cell Therapy: Perspective on Next-Generation CARs
Eduardo Laborda,
Travis S Young
14 May 2018
Expert Insight
Read more

Innovator Insight

Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes

Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes
Atherly Pennybaker,
Randall Alfano
29 May 2018
Innovator Insight
Read more
The Importance of Collection, Processing & Biopreservation Best Practices in Determining CAR-T Starting Material Quality

The Importance of Collection, Processing & Biopreservation Best Practices in Determining CAR-T Starting Material Quality
Lou Juliano,
George Eastwood
29 May 2018
Innovator Insight
Read more

Interview

Challenges in Developing GMP-Compliant Manufacturing Facilities for CAR-T Cells

Challenges in Developing GMP-Compliant Manufacturing Facilities for CAR-T Cells
Lothar Germeroth
6 June 2018
Interview
Read more
Innovative Technologies for CAR-T Manufacturing: the Key to Commercialization

Innovative Technologies for CAR-T Manufacturing: the Key to Commercialization
Stanley Kowalski,
Daniella Kranjac
4 June 2018
Interview
Read more
Unlocking the Potential of CAR-T Therapies for Solid Tumors

Unlocking the Potential of CAR-T Therapies for Solid Tumors
Tamara J Laskowski
4 June 2018
Interview
Read more
Driving CAR-T Manufacture Optimization through Technology Innovation

Driving CAR-T Manufacture Optimization through Technology Innovation
Philip H Coelho
4 June 2018
Interview
Read more
Addressing the Challenges of Commercial-Scale Manufacture of Viral Vectors for CAR-T Therapies

Addressing the Challenges of Commercial-Scale Manufacture of Viral Vectors for CAR-T Therapies
Calley Hirsch,
Xavier de Mollerat du Jeu
29 May 2018
Interview
Read more
Pricing Models & Strategies to Make CAR-T Therapy Affordable

Pricing Models & Strategies to Make CAR-T Therapy Affordable
Dan Ollendorf
14 May 2018
Interview
Read more
Advances in using CAR-T cell therapy to treat HIV

Advances in using CAR-T cell therapy to treat HIV
Scott Kitchen
14 May 2018
Interview
Read more
Commercial Business Models for Immunotherapies

Commercial Business Models for Immunotherapies
Helen Tayton-Martin
14 May 2018
Interview
Read more
Utlization of CAR-T therapy for ovarian cancer

Utlization of CAR-T therapy for ovarian cancer
Janos Tanyi
14 May 2018
Interview
Read more

Other articles

Interview

Fixing the weak links in the cell therapy manufacturing chain: processes, people and partnerships

Fixing the weak links in the cell therapy manufacturing chain: processes, people and partnerships
Phil Vanek
30 April 2018
Interview
Read more

Podcast

Fixing the weak links in the cell therapy manufacturing chain: processes, people and partnerships

Fixing the weak links in the cell therapy manufacturing chain: processes, people and partnerships
Phil Vanek
8 May 2018
Podcast
Listen now

Commercial Insights

Cell & Gene Therapy Commercial Insight – April 2018

Cell & Gene Therapy Commercial Insight – April 2018
Mark Curtis,
Richard Philipson
16 May 2018
Commercial Insights
Read more

Webinars

Advances in CAR-T manufacture – Bridging the commercialization gaps

Advances in CAR-T manufacture – Bridging the commercialization gaps
Ian Johnston
Ian Johnston, Senior Project Manager, R&D
Krishnendu Roy
Krishnendu Roy, Professor, Director, Marcus Center for Therapeutic Cell Characterization & Manufacturing (MC3M) at Georgia Institute of Technology
Greg Russotti
Greg Russotti, Vice President, Technical Operations at Celgene Corporation
28 June 2018
Webinar
Watch now